Elsevier

Virology

Volume 181, Issue 1, March 1991, Pages 165-171
Virology

Productive infection of CD4+ cells by selected hiv strains is not inhibited by Anti-CD4 monoclonal antibodies

https://doi.org/10.1016/0042-6822(91)90481-PGet rights and content

Abstract

Differential susceptibility of four diverse HIV strains to inhibition of infection of CD4+ CEM cells by anti-CD4 monoclonal antibodies was studied. The highly cytopathic HIV-1 246 and NDK strains were able to infect CEM cells and undergo several cycles of replication at saturating doses of LEU3-A, OKT4-A, and 13138-2 monoclonal antibodies, whereas propagation of reference HIV-1 BRU and weakly cytopathic strain HIV-1 PAS was inhibited. Postadsorption treatment by anti-CD4 antibodies had stronger inhibitory effect than did treatment during the virus adsorption period. In parallel experiments, the same monoclonal antibodies successfully blocked syncytium formation between uninfected MT4 cells and CEM cells infected by all four HIV-1 virus strains tested. To explain these seemingly contradictory data we have postulated that anti-CD4 antibodies efficiently inhibit cell-to-cell but not virus-to-cell infection.

References (24)

  • P.R Clapham et al.

    Soluble CDA blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells

    Nature (London)

    (1989)
  • E.S Daar et al.

    High concentration of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

  • Cited by (64)

    • Isolation and NMR characterization of rosacelose, a novel sulfated polysaccharide from the sponge Mixylla rosacea

      2001, Carbohydrate Research
      Citation Excerpt :

      The NOESY spectra were acquired with mixing times of 25, 50 and 100 ms, 256 scans/t1 value and t1max=37.3 ms. The NMR data were processed on a Silicon Graphic Indigo2 workstation using uxnmr software. Rosacelose (1) has been evaluated for its potential antiviral activity against HIV-1 at Campus Universitaire de Luminy, Marseille, France by Dr J.C. Chermann, by meaning the efficiency of the substrate to inhibit syncytia formation after HIV infection of MT4 cell line, as described previously.43,44 The experimental IC50 value was 5 μg/mL.

    • Dragmacidin F: A new antiviral bromoindole alkaloid from the mediterranean sponge Halicortex sp.

      2000, Tetrahedron
      Citation Excerpt :

      The activity was expressed as antiviral effective concentration that achieved 50% protection (EC50) of virus-infected cells from the HSV-induced destruction.17,18 Anti HIV-1 activity was monitored by the efficiency of the drug compound to inhibit syncytia formation after HIV-infection of MT4, as described elsewhere.19,20 The inhibitory concentration of drug compound was expressed as the concentration that caused 50% inhibition of syncytia formation (EC50) without direct toxicity for the cells.

    • New anti-HIV derivatives: Synthesis and antiviral evaluation

      2000, Bioorganic and Medicinal Chemistry
    View all citing articles on Scopus
    View full text